Real-world vaccination status of children with hematologic tumors before and after chemotherapy

References

• Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18:719–731.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone A, Krapcho M, et al. SEER Cancer Stat Rev. 2013;1975–2010. https://seer.cancer.gov/archive/csr/1975_2010/index.html#contents
   Google Scholar
• Johnston WT, Erdmann F, Newton R, et al. Childhood cancer: estimating regional and global incidence. Cancer Epidemiol. 2021;71:101662.
   PubMed Web of Science ®Google Scholar
• Bhakta N, Force LM, Allemani C, et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019;20:e42–53.
   PubMed Web of Science ®Google Scholar
• Zheng R, Peng X, Zeng H, et al. Incidence, mortality and survival of childhood cancer in China during 2000-2010 period: a population-based study. Cancer Lett. 2015;363:176–180.
   PubMed Web of Science ®Google Scholar
• Zhou YL, An JL, Tian L. Epidemiological analysis of childhood cancer in China]. Zhongguo dang dai er ke za zhi =. Chin J Contemp Pediatr. 2015;17:649–654.
   Google Scholar
• Jacola LM, Edelstein K, Liu W, et al. Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the childhood cancer survivor study. Lancet Psychiatry. 2016;3:965–972.
   PubMed Web of Science ®Google Scholar
• Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110:3532–3539.
   PubMed Web of Science ®Google Scholar
• Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. Cancer. 2014;120:2514–2521.
   PubMed Web of Science ®Google Scholar
• So W, Pandya S, Quilitz R, et al. Infectious risks and complications in adult leukemic patients receiving blinatumomab. Mediterr J Hematol Infect Dis. 2018;10:e2018029.
   PubMed Web of Science ®Google Scholar
• Arad-Cohen N, Rowe JM, Shachor-Meyouhas Y. Pharmacological prophylaxis of infection in pediatric acute myeloid leukemia patients. Expert Opin Pharmacother. 2020;21:193–205.
   PubMed Web of Science ®Google Scholar
• Fioredda F, Plebani A, Hanau G, et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy. Eur J Haematol. 2005;74:20–23.
   PubMed Web of Science ®Google Scholar
• Viana SS, Araujo GS, Faro GB, et al. Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia. Revista brasileira de hematologia e hemoterapia. 2012;34:275–279. DOI:10.5581/1516-8484.20120071.
   Google Scholar
• Toret E, Yel SE, Suman M. Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors. 2021;17:1132–1135. DOI:10.1080/21645515.2020.1802975.
   Google Scholar
• National Health Commission of the People’s Republic of China, editor. National immunization program vaccine children’s immunization procedures and instructions. 2021. Available at: http://www.nhc.gov.cn/jkj/s3581/202103/590a8c7915054aa682a8d2ae8199e222.shtml.
   Google Scholar
• Li M, Ji C, Wang B, et al. Incomplete vaccination among children with special health care needs in Zhejiang, China: analysis of retrospective data. Front Pediatr. 2019;7:173.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–4164.
   PubMed Web of Science ®Google Scholar
• Kempe A, Saville AW, Albertin C, et al. Parental hesitancy about routine childhood and influenza vaccinations: a national survey. Pediatrics. 2020;146. DOI:10.1542/peds.2019-3852.
   PubMed Web of Science ®Google Scholar
• Li K, Zhang L, Ye J, et al. Surveillance of suspected abnormal reactions to vaccination in China in 2017. China Vaccines and Immunol. 2020;26:9–18.
   Google Scholar
• Malagoli C, Malavolti M, Costanzini S, et al. Increased incidence of childhood leukemia in urban areas: a population-based case-control study. Epidemiol Prev. 2015;39:102–107.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Li Q, Yao K. Epidemiological analysis of pediatric tumor in Jiashan County from 1987 to 2015. Chin J Rural Med. 2017;24:69–70.
   Google Scholar
• Ye J, Cao L, Yu W. Surveillance of routine immunization coverage rate of national immunization program vaccines among school-age children in China from 2016 to 2019. Chin J Vaccin Immunol. 2022;28:94–100.
   Google Scholar
• Cao L, Wang H, Zheng J. Investigation and analysis of the vaccination rate of the expanded national immunization program in China. China Vaccines Immun. 2012;18:419–424.
   Google Scholar
• Wang W, Wang H. Analysis of current situation and influencing factors of non-immunization program vaccine in China. Chin J Vaccin Immunol. 2020;26:93–97.
   Google Scholar
• Nie X. Analysis of factors influencing the timely rate of immunization program vaccine among floating children. Chin Rural Health. 2020;12:12.
   Google Scholar
• Yuan Q, Gao Y. Preventive vaccination plan and implementation of children with hematologic tumor recovery. Chin J Pract Pediatr. 2021;36:236–240.
   Google Scholar
• Rubin LG, Levin MJ, Ljungman P, et al. IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2013;2014(58):309–318. DOI:10.1093/cid/cit816
   Google Scholar
• Ruan HS, Gao YJ, Fei Y, et al. Preliminary practice of multidisciplinary cooperative vaccination management model for pediatric patients with hematological and oncological diseases. Zhonghua Er Ke Za Zhi. 2021;59:305–310.
   PubMedGoogle Scholar
• Li J. Expert consensus on preventive vaccination of children with special health status - chemotherapy and preventive vaccination for leukemia. Chin J Pract Pediatr. 2019;34:266–267.
   Google Scholar
• Fouda AE, Kandil SM, Boujettif F, et al. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination. Hematology. 2018;23:590–595.
   PubMed Web of Science ®Google Scholar
• Bonaventure A, Harewood R, Stiller CA, et al. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4:e202–17.
   PubMed Web of Science ®Google Scholar
• Saghafian-Hedengren S, Söderström I, Sverremark-Ekström E, et al. Insights into defective serological memory after acute lymphoblastic leukaemia treatment: the role of the plasma cell survival niche, memory B-cells and gut microbiota in vaccine responses. Blood Rev. 2018;32:71–80.
   PubMed Web of Science ®Google Scholar